Patients with hidradenitis suppurativa (HS) who started on or switched to biosimilar adalimumab experienced lower treatment success and lost response more quickly, according to an Australian study ...
PhilHealth Bukidnon chief Romulo M. Lapuz Jr. announces the expanded YAKAP coverage, which now includes 75 types of medicines and six cancer-screening tests in accredited facilities. He said ongoing ...
In 2026, there are fewer prescription drug plans in Medicare Part D and higher premiums, even when offset by a ...
The Board of Medicine is the state’s primary regulatory body setting medical practice and physician licensing standards. The ...
Patients with Crohn disease report high satisfaction and minimal discomfort using the citrate-free biosimilar CT-P17, enhancing adherence to treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback